21 – 30 of 2067
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cognitive Safety is Largely Ignored in Clinical Drug Trials : A Study of Registered Study Protocols
(
- Contribution to journal › Article
-
Mark
Dose-dependent effects of acetaminophen and ibuprofen on mitochondrial respiration of human platelets
(
- Contribution to journal › Article
-
Mark
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders
(
- Contribution to journal › Scientific review
-
Mark
Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteers
(
- Contribution to journal › Article
-
Mark
Prospective Study of Mercury Exposure from Pregnancy and Its Relation with Telomere Length in Spanish Children
2024) In Exposure and Health(
- Contribution to journal › Article
-
Mark
Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver
(
- Contribution to journal › Article
-
Mark
Sex differences in expression of CGRP family of receptors and ligands in the rat trigeminal system
(
- Contribution to journal › Article
-
Mark
Is the shift in treatment patterns toward new, more expensive drugs still driving the increase in pharmaceutical expenditure? : A decomposition analysis of expenditure data in Sweden 1990-2022
2024) In Expert Review of Pharmacoeconomics & Outcomes Research(
- Contribution to journal › Article
-
Mark
Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking
(
- Contribution to journal › Article
-
Mark
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis
(
- Contribution to journal › Article